Studies showed that SIRT3 expression could significantly decrease in the brains of HD patients, which correlates with overactivation of NMDA receptors mediated by NMDA receptor 2B, mitochondrial dysfunction, and impaired synaptic plasticity (Buck et al., 2017; Someya et al., 2010). The gene discussed is SIRT3; the disease is Huntington disease.